Company intelligence / Profile preview

Koura

Ince, Chester, Cheshire, United Kingdomkouraglobal.com ↗

Ownership: Private
Employees: ~1600
Development stage: Commercial

Overview

Koura, part of Orbia Fluor & Energy Materials, is a global leader in fluoroproducts—especially fluorspar and hydrofluoric acid—and commercializes medical propellants (Zephex® series) widely used in metered dose inhalers. Their new Zephex 152a offers >90% reduced global warming potential compared to traditional propellants and is now in commercial production for the pharmaceutical industry[1][7].

Therapeutic areas: Pulmonology
Modalities: Medical propellantActive pharmaceutical ingredientSmall molecule
Industry: Chemicals & Materials

Partnerships

Bespak (to commercialize low GWP inhalers with Zephex 152a)[7]

Beyond the preview

Go deeper on Koura.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Koura.

Explore the full profile